Novel KRAS Drug Shows 'Excellent' Efficacy in Tough-to-Treat Lung Cancer
Summary
Zoldonrasib ideal for further evaluation in <em>KRAS</em> G12D-mutant disease, expert says
Description
Zoldonrasib ideal for further evaluation in <em>KRAS</em> G12D-mutant disease, expert says
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source